GlassScriptPhysician profile
Loyal R Stierlen
NPI 1447275052
$4,199.31
in general payments reported to CMS, 2019-2025
12 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,235 · 2020: $142 · 2021: $87.50 · 2022: $72.80 · 2023: $58.27 · 2024: $1,412 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $871 · Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $871.08 |
| Food and Beverage | $790.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,300.26 | 2019-2024 | |
| Enterra Medical, INC. | $1,079.89 | 2024 | |
| Davol INC. | $259.46 | 2023-2025 | Phasix Mesh |
| Organogenesis INC. | $103.78 | 2019 | |
| Tas Medical, INC. | $90.28 | 2024 | |
| Polynovo North America LLC | $86.33 | 2022-2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $77.76 | 2019-2020 | |
| Allergan, INC. | $60.55 | 2021-2022 | |
| Acera Surgical, INC. | $49.39 | 2025 | Restrata Wound Matrix |
| Abbvie INC. | $47.86 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Acell, INC. | $29.65 | 2019 | |
| Teleflex LLC | $14.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loyal Stierlen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.